Use of 18FDG-PET to discriminate between infection and rejection in lung transplant recipients
Use of 18FDG-PET to discriminate between infection and rejection in lung transplant recipients
复制标题
DOI:
10.1097/01.tp.0000121767.05724.33
复制
发表时间:
2004-05-15
期刊:
影响因子:
6.2
通讯作者:
Chilvers, ER
中科院分区:
文献类型:
--
作者:
Jones, HA;Donovan, T;Chilvers, ER
F-18-fluorodeoxyglucose ((18)FDG) uptake measured by positron emission tomography (PET) allows assessment of neutrophil activity in vivo and is increased in patients with airway inflammation or infection. Because infection but not rejection elicits a highly neutrophilic response, we assessed the ability of this noninvasive technique to differentiate these two events in lung transplant recipients. (18)FDG-PET was measured in 15 patients classified by clinical, radiologic, and pathologic criteria. (18)FDG-PET signal was increased with proven infection but not when no infection was identified (mean [standard error of mean]: 8.00 [1.81] and 3.16 [0.61], respectively [P=0.021]. Rejection alone did not increase the signal. These data confirm that neutrophil activation is not a feature of acute rejection and indicate that a high (18)FDG-PET signal is indicative of infection but not rejection in lung transplant recipients. This non-invasive and repeatable test could reduce the number of transbronchial biopsies required during episodes of breathlessness after lung transplantation.